Knockdown of NANOG or HDAC1 with a siRNA robustly dampened expression of the effectors of NANOG signaling, such as CXCL10 and MCL1, across all tested cancer cells (Figure 6A and Supplemental Figure 15). This evidence concerns the gene CXCL10 and cancer.